External validation of the T.O.HO. score as predictor of success after retrograde intrarenal surgery.


Journal

BMC urology
ISSN: 1471-2490
Titre abrégé: BMC Urol
Pays: England
ID NLM: 100968571

Informations de publication

Date de publication:
24 Apr 2022
Historique:
received: 15 11 2021
accepted: 13 04 2022
entrez: 25 4 2022
pubmed: 26 4 2022
medline: 27 4 2022
Statut: epublish

Résumé

To assess the effectiveness of T.O.HO. (Tallness, Occupied lesion, Houndsfield unit evaluation) score in predicting the retrograde intrarenal surgery (RIRS) success and to validate this scoring system. The age, sex, previous stone surgery, hospitalization, surgery duration, postoperative complication, stone length, stone location, stone density, stone number, lateralization, presence of hydronephrosis, and presence of preoperative stent datas of 611 patients who underwent RIRS in our clinic between January 2013 and January 2021 were retrospectively assessed. The patients were divided into two groups as successful and unsuccessful. The T.O.HO scores of all patients were calculated. The success rate was 72.5%. Compared to the unsuccessful group, stone length and stone density were lower, surgery duration was shorter and there were less lower pole stones in the successful group (p < 0.001). No significant difference was found between the two groups in terms of the other parameters. The T.O.HO. score was significantly lower in the successful group compared to the unsuccessful group (p < 0.001). According to the multivariate logistic regression analysis, stone length (OR: 0.905; 95% Cl: 0.866-0.946; p < 0.001), lower pole location (OR: 0.546; 95% Cl: 0.013-0.296; p < 0.001), stone density (OR: 0.999; 95% Cl: 0.998-1; p = 0.044) and the T.O.HO. score (OR: 0.684; 95%Cl: 0.554-0.844; p < 0.001) were found as the independent risk factors for RIRS success. ROC curve analysis showed that the T.O.HO. score could predict the RIRS success with 7.5 cut-off point (AUC: 0.799, CI: 0.76-0.839; p < 0.001). The T.O.HO. score can predict RIRS success with a high rate of accuracy.

Sections du résumé

BACKGROUND BACKGROUND
To assess the effectiveness of T.O.HO. (Tallness, Occupied lesion, Houndsfield unit evaluation) score in predicting the retrograde intrarenal surgery (RIRS) success and to validate this scoring system.
METHODS METHODS
The age, sex, previous stone surgery, hospitalization, surgery duration, postoperative complication, stone length, stone location, stone density, stone number, lateralization, presence of hydronephrosis, and presence of preoperative stent datas of 611 patients who underwent RIRS in our clinic between January 2013 and January 2021 were retrospectively assessed. The patients were divided into two groups as successful and unsuccessful. The T.O.HO scores of all patients were calculated.
RESULTS RESULTS
The success rate was 72.5%. Compared to the unsuccessful group, stone length and stone density were lower, surgery duration was shorter and there were less lower pole stones in the successful group (p < 0.001). No significant difference was found between the two groups in terms of the other parameters. The T.O.HO. score was significantly lower in the successful group compared to the unsuccessful group (p < 0.001). According to the multivariate logistic regression analysis, stone length (OR: 0.905; 95% Cl: 0.866-0.946; p < 0.001), lower pole location (OR: 0.546; 95% Cl: 0.013-0.296; p < 0.001), stone density (OR: 0.999; 95% Cl: 0.998-1; p = 0.044) and the T.O.HO. score (OR: 0.684; 95%Cl: 0.554-0.844; p < 0.001) were found as the independent risk factors for RIRS success. ROC curve analysis showed that the T.O.HO. score could predict the RIRS success with 7.5 cut-off point (AUC: 0.799, CI: 0.76-0.839; p < 0.001).
CONCLUSION CONCLUSIONS
The T.O.HO. score can predict RIRS success with a high rate of accuracy.

Identifiants

pubmed: 35462554
doi: 10.1186/s12894-022-01018-3
pii: 10.1186/s12894-022-01018-3
pmc: PMC9036695
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

68

Informations de copyright

© 2022. The Author(s).

Références

PLoS One. 2019 Feb 21;14(2):e0211316
pubmed: 30789937
Int J Clin Pract. 2021 Oct;75(10):e14653
pubmed: 34320257
Int Braz J Urol. 2014 Jan-Feb;40(1):23-9
pubmed: 24642147
Biomed J. 2014 Jan-Feb;37(1):24-30
pubmed: 24667675
J Endourol. 2021 Dec;35(12):1863-1882
pubmed: 33878937
Int Urol Nephrol. 2016 Aug;48(8):1247-1252
pubmed: 27160221
Asian J Urol. 2018 Oct;5(4):205-214
pubmed: 30364478
Arch Esp Urol. 2010 Dec;63(10):862-70
pubmed: 21187569
J Endourol. 2012 Oct;26(10):1257-63
pubmed: 22642568
Curr Urol Rep. 2021 Oct 8;22(10):50
pubmed: 34622358
J Endourol. 2017 Aug;31(8):729-735
pubmed: 28338351
Korean J Urol. 2010 Nov;51(11):777-82
pubmed: 21165199
J Endourol. 2012 May;26(5):489-93
pubmed: 22142335
Urology. 2012 Sep;80(3):512-8
pubmed: 22840867
Int J Urol. 2020 Sep;27(9):742-747
pubmed: 32594597
Urolithiasis. 2018 Apr;46(2):197-202
pubmed: 28236022
BMC Urol. 2017 Nov 21;17(1):105
pubmed: 29162070

Auteurs

Samet Senel (S)

Department of Urology, Ankara City Hospital, Üniversiteler, Bilkent Blv. No: 1, 06800, Çankaya, Ankara, Turkey. samet_senel_umt@hotmail.com.

Yusuf Kasap (Y)

Department of Urology, Ankara City Hospital, Üniversiteler, Bilkent Blv. No: 1, 06800, Çankaya, Ankara, Turkey.

Yalcin Kizilkan (Y)

Department of Urology, Ankara City Hospital, Üniversiteler, Bilkent Blv. No: 1, 06800, Çankaya, Ankara, Turkey.

Sedat Tastemur (S)

Department of Urology, Ankara City Hospital, Üniversiteler, Bilkent Blv. No: 1, 06800, Çankaya, Ankara, Turkey.

Cuneyt Ozden (C)

Department of Urology, Ankara City Hospital, Üniversiteler, Bilkent Blv. No: 1, 06800, Çankaya, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH